Pharming Group N.V.
PHGUF
$1.24
-$0.01-0.58%
OTC PK
| 03/31/2026 | 12/31/2025 | 06/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | 339.84M | 320.71M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | 339.84M | 320.71M |
| Cost of Revenue | -- | -- | -- | 36.33M | 35.34M |
| Gross Profit | -- | -- | -- | 303.51M | 285.37M |
| SG&A Expenses | -- | -- | -- | 204.85M | 196.15M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -3.15M | -2.22M |
| Total Operating Expenses | -- | -- | -- | 327.99M | 315.03M |
| Operating Income | -- | -- | -- | 11.84M | 5.67M |
| Income Before Tax | -- | -- | -- | 3.48M | -3.66M |
| Income Tax Expenses | -- | -- | -- | 12.00M | 10.63M |
| Earnings from Continuing Operations | -- | -- | -- | -8.51 | -14.28 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | 313.00K | 169.00K |
| Net Income | -- | -- | -- | -8.20M | -14.11M |
| EBIT | -- | -- | -- | 11.84M | 5.67M |
| EBITDA | -- | -- | -- | 27.82M | 22.38M |
| EPS Basic | -- | -- | -- | -0.01 | -0.02 |
| Normalized Basic EPS | -- | -- | -- | 0.00 | 0.00 |
| EPS Diluted | -- | -- | -- | -0.01 | -0.02 |
| Normalized Diluted EPS | -- | -- | -- | 0.00 | 0.00 |
| Average Basic Shares Outstanding | -- | -- | -- | 2.61B | 2.62B |
| Average Diluted Shares Outstanding | -- | -- | -- | 2.61B | 2.62B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |